1991, Volume 37, Issue 3 |
|
2-5 |
Dushkin M.I., Mandrikova E.V., Dolgov A.V. Esterification of cholesterol oxidation products and their effect on the rate of cholesterol esterification in macrophages
|
|
5-9 |
Panin L.E., Kuz'menko D.I. Features of oxidation of reserve lipids in liver mitochondria during starvation: the role of non-heme iron and free radical fatty acid oxidation
|
|
9-13 |
Dolgikh V.T. The effect of acute fatal blood loss on post-resuscitation changes in heart phospholipids and prevention of them
|
|
14-17 |
Gul'nik S.V., Feokharus G., Varchenko N.V., Lavrenova G.I., Stepanov V.M. The effect of Legionella pneumophila metalloproteinase on certain human blood proteins. Cleavage of anti(1)-antitrypsin and acid-stable serine proteinase inhibitors
|
|
17-19 |
Kozlov E.A., Bagdatlishvili G.I., Prozorovskaia N.N., Del'vig A.A. Comparative characteristics of oxyproline excretion in urine in children with post-burn hypertrophic and keloid scars
|
|
20-21 |
Kondratenko T.Ia., Kuzina N.V., Severin E.S., Kornilova Z.Kh., Tikhomirov E.V., Perel'man M.I. Chronic pneumonia and cancer: changes in beta-adrenergic receptors in human lung parenchyma
|
|
21-24 |
Danilovskii M.A., Loseva I.V., Krasil'nikova I.V., Sviridov B.N. Biochemical mechanisms of compensation for unilateral motor disorders of central genesis and their connection with the immune system
|
|
24-26 |
Shutenko Zh.V., Priedena I.A., Kalvin'sh I.Ia., Lukevits E.Ia. The effect of a structural analog of gamma-butyrobetaine, mildronate, 3-2,2,2-trimethylhydrazine)propionate on dynamic carnitine-dependent metabolism
|
|
26-28 |
Grin'ko I.V., Krivchik A.A., Ivankova O.V. Functional state of the liver during development of extrahepatic cholestasis and during use of enterosorption
|
|
28-30 |
Semenov V.L., Iarosh A.M. Disruption of energy metabolism in the liver during lung inflammation in rats
|
|
31-32 |
Kozlov S.A., Uriupov O.Yu., Tomchin A.B., Kiselev E.N. Effectiveness of a series of pharmacological substances in liver ischemia
|
|
33-35 |
Shneĭvaĭs V.B., Amilov K.S. Role of lipid peroxidation in pathogenesis of visceral ischemic shock
|
|
35-37 |
Kazachkina N.I., Nemtsova E.R., Iakubovskaia R.I., Karmakova T.A., Ivanova L.M., Sokolov A.V. Pharmacokinetics of human milk lactoferrin in intact mice and tumor-carrying animals
|
|
37-40 |
Mal'dov D.G., Zbarskii I.B. Protein kinase activity of proteins extracted by triton X-100 from isolated rat liver cell nuclei and Zajdela hepatoma
|
|
41-43 |
Korolev V.A., Golovskaia G.G., Selivanova K.F., Moldovan K.I., Borisenko S.N. Level of hemoglobin A1c and modified blood serum albumin in patients with diabetes mellitus
|
|
43-45 |
Gulieva S.A., Samedov S.I. Fatty acid composition of blood plasma of rabbits treated with naphthalene oil
|
|
45-47 |
Zakharian A.K., Amatuni V.G. The interconnection of changes in the level of prostaglandins, catecholamines, and lipid peroxidation of membrane lipids in patients with bronchial asthma
|
|
48-50 |
Zorin N.A., Zhabin S.G., Belogorlova T.I., Arkhipova S.V. A comparative study of alpha2-macroglobulin and pregnancy-associated alpha2-glycoprotein and protein A as possible analogs
|
|
50-53 |
Panosian A.G., Arakelian O.N., Saakian E.G., Akopov S.E., Nazarian A.V., Gabriélian E.S. Level of monohydroxyeicosatetraenoic acid in the blood of patients with cerebral blood circulation disorders
|
|
53-54 |
Sultanova E.M., Mukhamedieva Sh.G., Sagdiev N.Zh., Kliuev O.A., Khadzhimetov A.A., Sultanov S.N., Avakov V.E., Salikhov Sh.I. Peptide endotoxins and disruption of the hemostasis system during a complicated pregnancy
|
|
54-56 |
Boiarinov G.A., Andreeva N.N. Changes in the fatty acid composition of myocardial phospholipids after hypothermic ischemia
|
|
56-58 |
Kal'sines P.I., Gonsales O.L., Kalel'e O., Armas F.A., Rodriges M., Smirnova I.P., Berezov T.T. Relationship of the levels of cholesterol and triglycerides in blood plasma in racial groups in Cuba
|
|
58-60 |
Biiasheva I.R., Mal'tsev G.Iu., Pustovoĭtov V.V., Loranskaia T.I. System of antioxidant defense and activity of lysosomal hydrolase in the stomach mucosa in ulcer disease
|
|
60-62 |
Butolin E.G., Sharaev P.N. Change in indicators of biopolymer metabolism in connective tissue upon central administration of angiotensin II
|
|
62-64 |
Galimov Sh.N., Kamilov F.Kh. The nicotinamide coenzyme system in experimental burn disease during prepubescence
|
|
64-67 |
Golubeva M.V., Lunga I.N., Shishkin S.S. Use of two-dimensional O'Farrell electrophoresis for studying polymorphism of blood proteins
|
|
67-68 |
Ermakov N.V., Ishkov A.G., Mikerov S.V., Miroshnichenko E.V. Fluorometric determination of monoaminoxidase activity with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine as substrate
|
|
68-70 |
Lukasheva E.V., Vesa V.S., Korpela T.K., Berezov T.T. A spectrophotometric method for determining the concentration of L-lysine using L-lysine-alpha-oxidase from Trichoderma sp. and 3,3',5,5'-tetramethylbenzidene dihydrochloride
|
|
71-72 |
Sergeev I.N., Terekhina T.A., Iakushina L.M., Spirichev V.B. A simple method of determining 1,25-(OH)2D (calcitriol) in blood
|
|
73-75 |
Karelin A.A., Andreev V.I., Korotkina R.N. Experience in using the automatic biochemical analyzer "Spectrum" from "Abbott Laboratories" in the clinical biochemistry laboratory of the Institute of Surgery named for A.V. Vishnevskiĭ of the Academy of Medical Sciences of the USSR.
|
|
76-78 |
Golosova T.V., Somova A.V., Margolina A.N., Guliaeva A.A. Serodiagnosis of infections transmitted by blood transfusions (HIV-1/HIV-2, HBV, CMV, HCV, HTI V-1), using the testing equipment from the firm "Abbott Laboratories"
|
|
79-80 |
Dronova O.M., Zhabina M.I., Diuzhikova E.V., Bagirova N.S., Sokolova E.N. Use of the automated microbiological system "Advantage" from the firm "Abbott Laboratories" in studying the etiological structure of nosocomial infections in an oncology clinic
|
|
80-82 |
Bogovskiĭ B.P., Barmanova E.Yu. Comparison of two methods for therapeutic drug monitoring: FPIA (TDx) and Emit
|
|
83-85 |
Siniukhin V.H., Nikolaeva N.P., Iarmolinskiĭ I.S., Darenkov A.F. Informative value of methods for determining cyclosporin A and its metabolites during its monitoring in blood of patients with a transplanted kidney
|
|
85-86 |
Dzgoev A.B., Eremin S.A., Danilova N.P., Egorov A.M., Vasilov R.G. Quantitative determination of phenobarbital in human blood serum by fluorescence polarization immunoanalysis
|
|
86-88 |
Gabrielian N.I., Savost'ianova O.A., Belotserkovskaia O.I. Monitoring cyclosporin in the treatment plan of patients during the post-transplant period
|
|